Increased Anti-Mu¨llerian Hormone Serum Concentrations in Prepubertal Daughters of Women with Polycystic Ovary Syndrome

Context: Anti-Mu¨llerian hormone (AMH) is produced by the gran- ulosa cells and reflects follicular development. Adult women with polycystic ovary syndrome (PCOS) have increased levels of AMH associated with an excessive number of growing follicles. However, it is not known whether these abnormalities are present before the clinical onset of PCOS. Objective: Our objective was to investigate whether prepubertal daughters of women with PCOS have increased AMH levels. Design: Fourteenfemaleinfants(2–3monthsold)and25prepubertal girls (4–7 yr old) born to PCOS mothers were studied. As a control group, we studied 21 female infants and 24 prepubertal girls born to mothers with regular menses and without hyperandrogenism. The group with PCOS mothers and the control group had normal birth weight and were born from spontaneous singleton pregnancies. Circulating concentrations of gonadotropins, testosterone, androstenedione, estradiol, 17-OH-progesterone, SHBG, inhibin B, and AMH were determined by specific assays. Results: Serum concentrations of AMH were significantly higher in thePCOSgroupcomparedwiththecontrolgroupduringearlyinfancy(20.4 Gonadotropin and serum sex steroid concentrations were similar in both groups during the two study periods, except for FSH, which was lower during childhood in girls born to PCOS mothers. Conclusions: We conclude that serum AMH concentrations are in- creased in prepubertal daughters of PCOS women, suggesting that these girls appear to show evidence of an altered follicular develop- ment during infancy and childhood. ( J Clin Endocrinol Metab 91: 3105–3109, 2006)

[1]  D. Dewailly,et al.  Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. , 2006, The Journal of clinical endocrinology and metabolism.

[2]  R. Rey,et al.  Low risk of impaired testicular Sertoli and Leydig cell functions in boys with isolated hypospadias. , 2005, The Journal of clinical endocrinology and metabolism.

[3]  E. Codner,et al.  Postnatal developmental consequences of altered insulin sensitivity in female sheep treated prenatally with testosterone. , 2005, American journal of physiology. Endocrinology and metabolism.

[4]  J. Stark,et al.  Anti-müllerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries. , 2005, The Journal of clinical endocrinology and metabolism.

[5]  E. Codner,et al.  Birth weight in offspring of mothers with polycystic ovarian syndrome. , 2005, Human reproduction.

[6]  S. Roy,et al.  Fetal programming: prenatal testosterone treatment causes intrauterine growth retardation, reduces ovarian reserve and increases ovarian follicular recruitment. , 2005, Endocrinology.

[7]  A. Ruokonen,et al.  Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. , 2005, Human reproduction.

[8]  M. Racine,et al.  Sex differences in FSH-regulatory peptides in pubertal age boys and girls and effects of sex steroid treatment. , 2004, Human reproduction.

[9]  D. Dewailly,et al.  The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. , 2004, Human reproduction update.

[10]  Morton B. Brown,et al.  Fetal programming: prenatal testosterone excess leads to fetal growth retardation and postnatal catch-up growth in sheep. , 2004, Endocrinology.

[11]  B. Fauser,et al.  Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. , 2004, Molecular human reproduction.

[12]  M. Maliqueo,et al.  Proinsulin serum concentrations in women with polycystic ovary syndrome: a marker of beta-cell dysfunction? , 2003, Human reproduction.

[13]  D. Dewailly,et al.  Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. , 2003, The Journal of clinical endocrinology and metabolism.

[14]  J. Stark,et al.  Formation and early development of follicles in the polycystic ovary , 2003, The Lancet.

[15]  J. Rosser,et al.  The surgical treatment of obesity: a personal perspective. , 2003, Journal of laparoendoscopic & advanced surgical techniques. Part A.

[16]  D. Dewailly,et al.  Ultrasound examination of polycystic ovaries: is it worth counting the follicles? , 2003, Human reproduction.

[17]  R. Fanchin,et al.  Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. , 2003, Human reproduction.

[18]  F. de Zegher,et al.  Anovulation in eumenorrheic, nonobese adolescent girls born small for gestational age: insulin sensitization induces ovulation, increases lean body mass, and reduces abdominal fat excess, dyslipidemia, and subclinical hyperandrogenism. , 2002, The Journal of clinical endocrinology and metabolism.

[19]  A. Tsatsoulis,et al.  The genetic basis of polycystic ovary syndrome. , 2002, European journal of endocrinology.

[20]  J. Visser,et al.  Regulation of ovarian function: the role of anti-Müllerian hormone. , 2002, Reproduction.

[21]  M. Maliqueo,et al.  Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. , 2002, Human reproduction.

[22]  S. Franks,et al.  Developmental origin of polycystic ovary syndrome - a hypothesis. , 2002, The Journal of endocrinology.

[23]  S. Rhind,et al.  Effects of nutrition and environmental factors on the fetal programming of the reproductive axis. , 2001, Reproduction.

[24]  M. Eijkemans,et al.  Absent biologically relevant associations between serum inhibin B concentrations and characteristics of polycystic ovary syndrome in normogonadotrophic anovulatory infertility. , 2001, Human reproduction.

[25]  Y. Siow,et al.  Serum müllerian-inhibiting substance levels during normal menstrual cycles. , 2000, Fertility and sterility.

[26]  D. Abbott,et al.  Timing of prenatal androgen excess determines differential impairment in insulin secretion and action in adult female rhesus monkeys. , 2000, The Journal of clinical endocrinology and metabolism.

[27]  A. Tchernitchin,et al.  Imprinting: Perinatal Exposures Cause the Development of Diseases During the Adult Age , 1999, Acta biologica Hungarica.

[28]  N. Skakkebaek,et al.  Expression of anti-Müllerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. , 1999, The Journal of clinical endocrinology and metabolism.

[29]  N. Josso,et al.  TGF-β Family Members and Gonadal Development , 1999, Trends in Endocrinology & Metabolism.

[30]  M. Urbanek,et al.  Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[31]  L. Aerts,et al.  Fetal growth and long-term consequences in animal models of growth retardation. , 1998, European journal of obstetrics, gynecology, and reproductive biology.

[32]  F. de Zegher,et al.  Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. , 1998, The Journal of clinical endocrinology and metabolism.

[33]  C. Bondy,et al.  Androgens stimulate early stages of follicular growth in the primate ovary. , 1998, The Journal of clinical investigation.

[34]  J. Toppari,et al.  Longitudinal reproductive hormone profiles in infants: peak of inhibin B levels in infant boys exceeds levels in adult men. , 1998, The Journal of clinical endocrinology and metabolism.

[35]  M. L. Gustafson,et al.  Measurements of serum müllerian inhibiting substance in the evaluation of children with nonpalpable gonads. , 1997, The New England journal of medicine.

[36]  M. Peschanski,et al.  ANTI-MULLERIAN HORMONE IN EARLY HUMAN DEVELOPMENT , 1993, Pediatric Research.

[37]  P. Donahoe,et al.  Mullerian inhibiting substance: a gonadal hormone with multiple functions. , 1993, Endocrine reviews.

[38]  J. Tapia,et al.  [Intrauterine growth in Chilean middle class newborn infants]. , 1989, Revista chilena de pediatría.

[39]  S. Reeders,et al.  FAMILIAL POLYCYSTIC OVARIES: A GENETIC DISEASE? , 1988, Clinical endocrinology.

[40]  J. Givens.  Familial polycystic ovarian disease. , 1988, Endocrinology and metabolism clinics of North America.

[41]  S. Franks,et al.  Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. , 1986, British medical journal.

[42]  D. Ferriman,et al.  THE INHERITANCE OF POLYCYSTIC OVARIAN DISEASE AND A POSSIBLE RELATIONSHIP TO PREMATURE BALDING , 1979, Clinical endocrinology.

[43]  H. E. Cooper,et al.  Hereditary factors in the Stein-Leventhal syndrome. , 1968, American journal of obstetrics and gynecology.

[44]  E. Codner,et al.  Response to the gonadotropin releasing hormone agonist leuprolide in immature female sheep androgenized in utero. , 2005, Biological research.

[45]  B. Fauser,et al.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.

[46]  C. Quigley.  The Postnatal Gonadotropin and Sex Steroid Surge—Insights from the Androgen Insensitivity Syndrome , 2002 .

[47]  A. Durlinger,et al.  Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary. , 1999, Endocrinology.

[48]  S. Imbeaud,et al.  Anti-müllerian hormone: the Jost factor. , 1993 .

[49]  P. Magnus,et al.  Familial clustering in the polycystic ovarian syndrome. , 1989, Gynecologic and obstetric investigation.

[50]  G. Okoev,et al.  [Diagnostic criteria for polycystic ovary syndrome]. , 1989, Akusherstvo i ginekologiia.

[51]  P. Hughesdon.  Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called "hyperthecosis". , 1982, Obstetrical & gynecological survey.